Note: The data below are based on cases identified as “Asperger Syndrome” N=1,366 PARENT RATINGS OF BEHAVIORAL EFFECTS OF BIOMEDICAL INTERVENTIONS Autism Research Institute ● 4182 Adams Avenue ● San Diego, CA 92116
The parents of autistic children represent a vast and important reservoir of information on the benefits—and adverse effects— of the large variety of drugs and other interventions that have been tried with their children. Since 1967 the Autism Research Institute has been collecting parent ratings of the usefulness of the many interventions tried on their autistic children. The following data have been collected from 1,366 parents who have completed our questionnaires designed to collect such information. For the purposes of the present table, the parents responses on a six-point scale have been combined into three categories: “made worse” (ratings 1 and 2), “no effect” (ratings 3 and 4), and “made better” (ratings 5 and 6). The “Better:Worse” column gives the number of children who “Got Better” for each one who “Got Worse.”
Parent Ratings Parent Ratings Parent Ratings Got No Got Better: No. of Got No Got Better: No. of Got No Got Better: No. of WorseA Effect Better Worse CasesB DRUGS WorseA Effect Better Worse CasesB DRUGS WorseA Effect Better Worse CasesB 53% 27% 1.3:1 DilantinD Prolixin 25% 34% 0.8:1 Behavior 1.2:1 185 Amphetamine 32% 28% 40% 1.2:1 Seizures Risperidal 2.6:1 210 Anafranil 46% 39% 2.6:1 Fenfluramine 13% 75% 13% 1.1:1 8 1.0:1 413 Antibiotics 43% 22% 0.6:1 AntifungalsC Secretin Intravenous 13% Diflucan 35% 60% 11:1 KlonapinD Transderm. 0% Nystatin 43% 50% 7.5:1 Behavior Stelazine 44% 24% 0.8:1 Seizures Steroids Benadryl 45% 24% 0.8:1 Beta Blocker 8% 54% 38% 5.0:1 TegretolD 46% 34% 1.7:1 Mellaril Behavior MysolineD Seizures 50% 17% 0.5:1 Behavior Thorazine Clonidine 38% 40% 1.8:1 Seizures Tofranil Clozapine 48% 22% 0.8:1 Naltrexone Cogentin 54% 23% 1.0:1 47% 18% 0.5:1 Naltreone ZarontinD DepakeneD Behavior Behavior 42% 34% 1.4:1 Phenobarb.D Seizures Seizures 48% 39% 3.0:1 Behavior 1.2:1 133 Desipramine 20% 47% 33% 1.7:1 Seizures BIOMEDICAL/ Parent Ratings BIOMEDICAL/ Parent Ratings NON-DRUG/ Got No Got Better: No. of NON-DRUG/ Got No Got Better: No. of SUPPLEMENTS WorseA Effect Better Worse CasesB SUPPLEMENTS WorseA Effect Better Worse CasesB CalciumE Transfer Factor 61% 33% 6.0:1 Cod Liver Oil Vitamin A 61% 34% 6.7:1 Cod Liver Oil with Vitamin B3 44% 50% 7.8:1 Bethanecol Vit. B6/Mag. 44% 52% 13:1 Colostrum Vitamin B12 (oral) 5% 40% 55% 12:1 Detox. (Chelation)C Vitamin C 49% 48% 14:1 Digestive Enzymes 39% 58% 15:1 Fatty Acids SPECIAL DIETS Candida Diet 34% 64% 30:1 Folic Acid Feingold Diet 35% 64% 70:1 Food Allergy Trtmnt 4% 34% Gluten- /Casein- 25% 72% 32:1 Hyperbaric Oxygen Free Diet Low Oxalate Diet Magnesium 49% 49% 27:1 Melatonin Chocolate Methyl B12 (nasal) Removed Eggs 58% 38% 9.0:1 Methyl B12 (subcut.) 12% 25% Removed Milk 39% 59% 28:1 MT Promoter Products/Dairy P5P (Vit. B6) Removed Sugar 46% 52% 18:1 Removed Wheat 36% 62% 40:1 Rotation Diet 37% 61% 23:1 St. Johns Wort Specific Carbo- 21% 74% 18:1 hydrate Diet
A. “Worse” refers only to worse behavior. Drugs, but not nutrients, typically also cause physical problems if used long-term. B. No. of cases is cumulative over several decades, so does not reflect current usage levels (e.g., Haldol is now seldom used). C. Antifungal drugs and chelation are used selectively, where evidence indicates they are needed. D. Seizure drugs: top line behavior effects, bottom line effects on seizures. E. Calcium effects are not due to dairy-free diet; statistics are similar for milk drinkers and non-milk drinkers.
Biosci. Biotechnol. Biochem., 68 (5), 1135–1138, 2004Suppressive Effects of Dietary Fiber in Yogurt on the PostprandialSerum Lipid Levels in Healthy Adult Male VolunteersShizuki KONDO, Jin-zhong XIAO,y Noritoshi TAKAHASHI, Kazuhiro MIYAJI,Keiji IWATSUKI, and Sadayuki KOKUBOFood Research and Development Laboratory, Morinaga Milk Industry Co., Ltd., Zama 228-8583, JapanReceived October 24,
DATASHEET Epiphen Solution (Vétoquinol UK Limited) Epiphen Solution Use of phenobarbitone in conjunction with primidone is notrecommended as primidone is predominantly metabolised tophenobarbitone. Presentation: Solution containing 4% Phenobarbitone PhEur Phenobarbitone may reduce the activity of some drugs by increasingthe rate of metabolism through induction of drug-metabolisingen